Delivery Order SPE2DE24D0013-SPE2D626F42FB

The Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $3,500 to Cepheid Inc. on February 4, 2026, with an ultimate completion date of February 11, 2026. This delivery order, issued without set-aside designation, is a child contract under a larger indefinite delivery vehicle and represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic solutions. Cepheid, headquartered in Sunnyvale, California, specializes in advanced molecular diagnostic systems and reagents, particularly its GeneXpert diagnostic platform used for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinical conditions. The contract will be performed at Cepheid's Sunnyvale facility.

This award reflects Cepheid's established position within the federal healthcare procurement landscape, supported by extensive existing contracts across multiple federal agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company maintains two significant indefinite delivery contracts with the VA, including a $32.8 million agreement with VISN 6 extending through September 2030 and a $6.7 million contract with VISN 17 through December 2029, which generate ongoing delivery orders for diagnostic reagents, test kits, and associated services. The modest value of this particular delivery order is consistent with Cepheid's historical pattern of receiving firm fixed-price orders ranging from under $100,000 to several million dollars for diagnostic supplies and maintenance services supporting federal clinical laboratory operations.